squamouscell carcinoma scc lung histologic type nonsmallcell lung carcinoma nsclc second prevalent type lung cancer lung adenocarcinoma originates bronchi tumor cells characterized squamous appearance similar one observed epidermal cells squamouscell carcinoma lung strongly associated tobacco smoking forms squamouscell lung carcinoma share signs symptoms forms lung cancer include worsening cough including hemoptysis chest pain shortness breath weight loss symptoms may result local invasion compression adjacent thoracic structures compression involving esophagus causing dysphagia compression involving laryngeal nerves causing change voice compression involving superior vena cava causing facial edema distant metastases may also cause pain show symptoms related squamouscell carcinoma lung closely correlated history tobacco smoking types lung cancer according nurses health study relative risk scc approximately among previous duration smoking years years compared relative risk increases approximately previous smoking duration years approximately often arises centrally larger bronchi often metastasizes locoregional lymph nodes particularly hilar nodes early course generally disseminates outside thorax somewhat later major types lung cancer large tumors may undergo central necrosis resulting cavitation squamouscell carcinoma often preceded years squamouscell metaplasia dysplasia respiratory epithelium bronchi later transforms carcinoma situcitation needed large scale studies cancer genome atlas tcga systematically characterized recurrent somatic alterations likely driving lung squamouscell carcinoma initiation squamouscell lung carcinoma one tumor types highest number mutations since smoking main driver disease strong mutagenic inactivating mutations lung scc affect many tumor suppressor genes mutated cases pten recurrent lossoffunction mutations observed also suggesting tumor suppressive role lung scc gene also implicated oncogene haematological hand recurrent gainoffunction mutations found oncogenes common oncogene copy number amplifications found pdgfra egfr deletions observed tumor suppressors pten alterations ones affecting shared lung scc common type nsclc lung adenocarcinoma conversely two main driver oncogenes latter egfr kras rarely mutated lung many gene mutations copy number alterations occur pathways whose deregulation seems important initiation progression tumor specifically belong oxidative stress response pathways alterations genes tend occur mutually exclusive fashion therefore pathway overall altered similarly squamous cell differentiation pathway whose components include altered tumors alterations receptor tyrosine kinase pathway also common widespread adenocarcinoma typecitation needed recently four mrna expression subtypes primitive basal secretory classical identified validated within squamouscell carcinoma primitive subtype correlates worse patient survival subtypes defined intrinsic expression differences provide possible foundation improved patient prognosis research individualized early squamouscell carcinoma lung generally squamouscell carcinoma situ asymptomatic may appear incidental imaging finding ct scan magnetic resonance imaging lung nodule eventually becomes symptomatic usually tumor mass begins obstruct lumen major bronchus often producing distal atelectasis infection cytopathology may detect atypical cells cytologic smear test sputum bronchoalveolar lavage samples endobronchial brushings histopathology requires least lung biopsy exams tumors range well differentiated showing keratin pearls cell junctions anaplastic minimal residual squamouscell classification lung divided squamous cell lung carcinomas categories keratinizing nonkeratinizing basaloid keratinizing scc harbor features keratinization nonkeratinizing scc lack features show squamous markers finally basaloid scc rare subset poorly differentiated squamous cell lung carcinoma previous variants papillary smallcell clearcell scc discarded current classification subtypes uncommon clear evidence prognostic significance subtyping lung squamous cell treatment lung squamouscell carcinoma depends many factors including stage resectability performance status genomic alterations acquired individual tumorcitation needed therapy earlystage scc mimics histologic types nsclc early stage ii iiia lung scc typically resected surgically cytotoxic chemotherapy andor radiation may used adjuvant therapy following surgery hand advanced metastatic recurrent lung scc given firstline systemic therapy palliative ie noncurative intent consisting cytotoxic chemotherapy commonly platinumbased doublet either cisplatin carboplatin used platinum development targeted therapies less rapid lung scc respect adenocarcinoma alk rearrangements egfr mutations targetable receptor tyrosine kinase inhibitors much less frequent former compared immunotherapy showing promising results nsclc agent nivolumab approved us food drug administration fda lung scc lung squamouscell carcinoma second common histologic type lung cancer adenocarcinoma reaching lung cancer cases relative incidence former steadily decreasing favor latter due decreasing smoking rates last much lung scc found attributable cigarette smoking incidence greater men httpsenwikipediaorgwikisquamouscellcarcinomaofthelung